S'abonner

Dengue fever mortality score: A novel decision rule to predict death from dengue fever - 22/11/17

Doi : 10.1016/j.jinf.2017.09.014 
Chien-Cheng Huang a, b, c, d, e, 1, Chien-Chin Hsu a, f, 1, How-Ran Guo b, g, Shih-Bin Su e, h, i, Hung-Jung Lin a, f, j, *
a Department of Emergency Medicine, Chi-Mei Medical Center, Tainan, Taiwan, ROC 
b Department of Environmental and Occupational Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan, ROC 
c Bachelor Program of Senior Service, Southern Taiwan University of Science and Technology, Tainan, Taiwan 
d Department of Geriatrics and Gerontology, Chi-Mei Medical Center, Tainan, Taiwan, ROC 
e Department of Occupational Medicine, Chi-Mei Medical Center, Tainan, Taiwan, ROC 
f Department of Biotechnology, Southern Taiwan University of Science and Technology, Tainan, Taiwan, ROC 
g Department of Occupational and Environmental Medicine, National Cheng Kung University Hospital, Tainan, Taiwan, ROC 
h Department of Leisure, Recreation and Tourism Management, Southern Taiwan University of Science and Technology, Tainan, Taiwan, ROC 
i Department of Medical Research, Chi-Mei Medical Center, Liouying, Tainan, Taiwan, ROC 
j Department of Emergency Medicine, Taipei Medical University, Taipei, Taiwan, ROC 

*Corresponding author. Department of Emergency Medicine, Chi-Mei Medical Center, 901 Zhonghua Road, Yongkang District, Tainan City 710, Taiwan.Department of Emergency MedicineChi-Mei Medical Center901 Zhonghua Road, Yongkang DistrictTainan CityTaiwan710

Highlights

Five independent mortality predictors were identified in this study: elderly age, hypotension, hemoptysis, diabetes mellitus, and chronic bedridden.
DFM score showed that the mortality risk ratios for scores 0, 1, 2, and ≥3 were 0.2%, 2.3%, 6.0%, and 45.5%, respectively.
Compared with score 0, the odds ratios for mortality were 12.73 for score 1, 34.21 for score 2, and 443.89 for score ≥3.
DFM score was a simple and easy method to help decision making, especially in the massive outbreak.

Le texte complet de cet article est disponible en PDF.

Summary

Objectives

Dengue fever (DF) is still a major challenge for public health, especially during massive outbreaks. We developed a novel prediction score to help decision making, which has not been performed till date.

Methods

We conducted a retrospective case-control study to recruit all the DF patients who visited a medical center during the 2015 DF outbreak. Demographic data, vital signs, symptoms/signs, chronic comorbidities, laboratory data, and 30-day mortality rates were included in the study. Univariate analysis and multivariate logistic regression analysis were used to identify the independent mortality predictors, which further formed the components of a DF mortality (DFM) score. Bootstrapping method was used to validate the DFM score.

Results

In total, a sample of 2358 DF patients was included in this study, which also consisted of 34 deaths (1.44%). Five independent mortality predictors were identified: elderly age (≥65 years), hypotension (systolic blood pressure <90 mmHg), hemoptysis, diabetes mellitus, and chronic bedridden. After assigning each predictor a score of “1”, we developed a DFM score (range: 0–5), which showed that the mortality risk ratios for scores 0, 1, 2, and ≥3 were 0.2%, 2.3%, 6.0%, and 45.5%, respectively. The area under the curve was 0.849 (95% confidence interval [CI]: 0.785–0.914), and Hosmer–Lemeshow goodness-of-fit was 0.642. Compared with score 0, the odds ratios for mortality were 12.73 (95% CI: 3.58–45.30) for score 1, 34.21 (95% CI: 9.75–119.99) for score 2, and 443.89 (95% CI: 86.06–2289.60) for score ≥3, with significant differences (all p values <0.001). The score ≥1 had a sensitivity of 91.2% for mortality and score ≥3 had a specificity of 99.7% for mortality.

Conclusions

DFM score was a simple and easy method to help decision making, especially in the massive outbreak. Further studies in other hospitals or nations are warranted to validate this score.

Le texte complet de cet article est disponible en PDF.

Keywords : Dengue fever, Mortality, Prediction, Score


Plan


© 2017  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 75 - N° 6

P. 532-540 - décembre 2017 Retour au numéro
Article précédent Article précédent
  • Capsule switching of Neisseria meningitidis sequence type 7 serogroup A to serogroup X
  • Xuemeng Ji, Ping-Ping Yao, Le-Yi Zhang, Yi Li, Fang Xu, Ling-Ling Mei, Shui-Rong Zhu, Yan-Jun Zhang, Han-Ping Zhu, Stijn van der Veen
| Article suivant Article suivant
  • Correlation of altered expression of a long non-coding RNA, NEAT1, in peripheral blood mononuclear cells with dengue disease progression
  • Abhay Deep Pandey, Saptamita Goswami, Shweta Shukla, Shaoli Das, Suman Ghosal, Manisha Pal, Bhaswati Bandyopadhyay, Vishnampettai Ramachandran, Nandita Basu, Vikas Sood, Priyanka Pandey, Jayprokas Chakrabarti, Sudhanshu Vrati, Arup Banerjee

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.